drugset / Trial / NCT02279134

Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

NCT02279134

Phase 2/3 Unknown 360 enrolled Zefen Xiao
RandomizedParallel-groupOpen-labelTreatment

Summary

This phase III trial is studying how well the combination of chemoradiation or radiation works in resected locally advanced cancer of the esophagus or gastroesophageal junction.

Timeline

Start
2014-10
Primary completion
2022-12
Completion
2024-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 50 mg/m2
Subject Cisplatin Other / unclassified 75 mg/m2
Subject Nedaplatin Small molecule 50 mg/m2
Subject Nedaplatin Small molecule 75 mg/m2
Subject Paclitaxel Small molecule 135 mg/m2
Subject Paclitaxel Small molecule 150 mg/m2

Indications